Both transcriptional receptor α (Erα or ER66), which stimulates cell proliferation, and transcriptional receptor β (Erβ), which facilitates cytostatic and differentiation processes, are involved in breast cancer progression [104,105]. Here, ESR1 is linked to breast cancer.